Pheneticillin
Chemical compound
- J01CE05 (WHO)
- (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxypropanoyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- 147-55-7 Y
- 272833
- 240055 N
- EFA30X554H
- D08350 Y
- ChEMBL1614637 N
- DTXSID6023448
- Interactive image
- CC(C(=O)N[C@H]1[C@@H]2N(C1=O)[C@H](C(S2)(C)C)C(=O)O)OC3=CC=CC=C3
InChI
- InChI=1S/C17H20N2O5S/c1-9(24-10-7-5-4-6-8-10)13(20)18-11-14(21)19-12(16(22)23)17(2,3)25-15(11)19/h4-9,11-12,15H,1-3H3,(H,18,20)(H,22,23)/t9?,11-,12+,15-/m1/s1 N
- Key:NONJJLVGHLVQQM-JHXYUMNGSA-N N
Pheneticillin (or phenethicillin) is a penicillin. It is not approved by the FDA for use in the United States.
References
- Index Nominum: International Drug Directory. Swiss Pharmaceutical Society. Jan 2000. p. 816. ISBN 978-3887630751. Retrieved 20 April 2015.
- Dougherty T, Pucci MJ (21 Dec 2011). Antibiotic Discovery and Development (2012 ed.). Springer. p. 86. ISBN 978-1461413998. Retrieved 20 April 2015.
- v
- t
- e
(inhibit synthesis
of peptidoglycan
layer of bacterial
cell wall by binding
to and inhibiting
PBPs, a group of
D-alanyl-D-alanine
transpeptidases)
Glycopeptides Lipoglycopeptides |
|
---|---|
Lipopeptides |
|
Polymyxins |
|
Other |
|
- Inhibit PG subunit synthesis and transport: NAM synthesis inhibition (Fosfomycin)
- DADAL/AR inhibitors (Cycloserine)
- bactoprenol inhibitors (Bacitracin)
- Hydrolyze NAM-NAG
- Tyrothricin
- Isoniazid#
- Teixobactin
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e